These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 317512
1. [Study of humoral and cellular immunity in the course of ovarian carcinoma]. Laghi V, Carella G, Burrai I, Sacco F, Margariti PA, Villani L, Benedetti Panici P. Minerva Ginecol; 1979 Oct 10; 31(10):737-46. PubMed ID: 317512 [No Abstract] [Full Text] [Related]
2. [Cellular and humoral immunity in patients with benign tumors and tumor-like formations of ovaries]. Selezneva ND, Kadagidze ZG, Andikian SI, Veskova TK, Zhogoleva IB. Sov Med; 1982 Oct 10; (4):37-41. PubMed ID: 6980484 [No Abstract] [Full Text] [Related]
7. [Modified E rosette test in patients with malignant ovarian neoplasms]. Simm S, Tomaszkiewicz T, Markowska J, Kominek P. Ginekol Pol; 1981 Mar 10; 52(3):225-30. PubMed ID: 6973504 [No Abstract] [Full Text] [Related]
8. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G. Gynecol Oncol; 1993 Feb 10; 48(2):148-54. PubMed ID: 8381375 [Abstract] [Full Text] [Related]
9. [Indicators of cellular and humoral immunity in patients with lichen ruber planus]. Chakhkiev RO. Vestn Dermatol Venerol; 1977 Sep 10; (9):14-7. PubMed ID: 303844 [No Abstract] [Full Text] [Related]
10. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation. Ramey WG, Hashim GA, Burrows WB, Swistel AJ, Munther A, Fitzpatrick HF. Cancer Res; 1979 Dec 10; 39(12):4796-801. PubMed ID: 315272 [No Abstract] [Full Text] [Related]
11. [Cellular and humoral immunity in children with lymphoblastic leukemia]. Jagielski P, Litwin J, Rokicka-Milewska R, Derulska D, Madaliński K. Pediatr Pol; 1981 Sep 10; 56(9):993-1001. PubMed ID: 6976553 [No Abstract] [Full Text] [Related]
12. T-cell functions in ovarian cancer patients treated with viral oncolysates: I. Increased helper activity to immunoglobulins production. Ioannides CG, Platsoucas CD, Patenia R, Kim YP, Bowen JM, Morris M, Edwards C, Wharton JT, Freedman RS. Anticancer Res; 1990 Sep 10; 10(3):645-53. PubMed ID: 2142392 [Abstract] [Full Text] [Related]
13. [Cellular and humoral immunity and systemic and regional fibrinolysis in patients with chronic suppurative bronchitis]. Bratchik AM, Beloglazov VA. Ter Arkh; 1988 Sep 10; 60(11):100-4. PubMed ID: 3266372 [Abstract] [Full Text] [Related]
14. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer]. Saitoh S, Nakanishi A, Noda T, Ando Y, Katakami Y, Kiyozuka Y, Moriyama I, Ichijo M. Nihon Gan Chiryo Gakkai Shi; 1984 Dec 20; 19(10):2327-35. PubMed ID: 6598184 [No Abstract] [Full Text] [Related]
16. [In vitro study of 6B11GM to induce cellular immunity in patients with ovarian carcinoma]. Yang F, Qian H, Feng J. Zhonghua Fu Chan Ke Za Zhi; 1999 Nov 20; 34(11):660-3. PubMed ID: 11479947 [Abstract] [Full Text] [Related]
17. [Clinical significance of the measurement of cellular immune status in patients with ovarian malignancies]. Ma D, Gu MJ. Zhonghua Fu Chan Ke Za Zhi; 1988 Mar 20; 23(2):99-101, 128. PubMed ID: 3263914 [No Abstract] [Full Text] [Related]
18. Cell-mediated and humoral types of immunologic immunity in idiopathic pancytopenia. Traczyk Z, Orczyńska E, Cieśluk S. Arch Immunol Ther Exp (Warsz); 1979 Mar 20; 27(1-2):1-7. PubMed ID: 312631 [Abstract] [Full Text] [Related]